Related Experiment Video
Updated: Jul 25, 2026

08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Nicotine-induced molecular alterations are modulated by GABAB receptor activity
Andres P Varani1, Valeria T Pedrón1, Amira J Aon1
1CONICET - Universidad de Buenos Aires, Instituto de Investigaciones Farmacológicas (ININFA), Buenos Aires, Argentina.
Addiction Biology
|April 19, 2017
Summary
GABAB receptors are crucial for controlling nicotine
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Nicotine's rewarding effects are modulated by GABAB receptors, but the underlying mechanisms remain unclear.
- Understanding these mechanisms is vital for developing targeted interventions for nicotine dependence.
Purpose of the Study:
- To investigate the role of GABAB receptors in the behavioral, neurochemical, biochemical, and molecular changes associated with nicotine reward.
- To elucidate the pharmacological and genetic mechanisms underlying GABAB receptor involvement in nicotine's effects.
Main Methods:
- Utilized the conditioned place preference (CPP) paradigm in mice to assess nicotine's rewarding properties.
- Administered GABAB receptor antagonist (2-hydroxysaclofen) and agonist (baclofen), and employed GABAB1 knockout mice.
- Analyzed neurochemical (dopamine, serotonin), biochemical (α4β2nAChRs density), and molecular (c-Fos expression) changes using HPLC, binding assays, and immunohistochemistry in key brain regions (Acb, PFC, VTA).
Main Results:
- Nicotine induced rewarding effects and altered dopamine levels, α4β2nAChRs density, and c-Fos expression.
- Baclofen treatment prevented these nicotine-induced alterations.
- GABAB receptor antagonism and genetic knockout potentiated these alterations, indicating GABAB receptor activity is necessary for control.
Conclusions:
- GABAB receptor activity is essential for regulating the behavioral, neurochemical, biochemical, and molecular effects of nicotine.
- These findings contribute significantly to understanding the intricate mechanisms of nicotine reward and may inform future therapeutic strategies.
Related Concept Videos
G-Protein Gated Ion Channels
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Sensory organs,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...

